-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Cut to $36.00 by Analysts at HC Wainwright
Day One Biopharmaceuticals (NASDAQ:DAWN – Free Report) had its price target lowered by HC Wainwright from $40.00 to $36.00 in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Day One Biopharmaceuticals’ Q1 2025 earnings at ($0.28) EPS, Q2 2025 […]
Day One Biopharmaceuticals (NASDAQ:DAWN – Free Report) had its price target lowered by HC Wainwright from $40.00 to $36.00 in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Day One Biopharmaceuticals’ Q1 2025 earnings at ($0.28) EPS, Q2 2025 […]
